We serve 4-ethenyl-2,3-dihydro-1-benzofuran CAS:230642-84-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 4-ethenyl-2,3-dihydro-1-benzofuran
CAS.NO:230642-84-9
Synonyms:
4-vinyl-2,3-dihydrobenzofuran
4-ethenyl-2,3-dihydrobenzofuran
Benzofuran,4-ethenyl-2,3-dihydro
Molecular Formula:C10H10O
Molecular Weight:146.18600
Physical and Chemical Properties:
Density: 1.079g/cm3
Boiling point: 244.265ºC at 760 mmHg
Melting point:/
Flash point:95.024ºC
Refractive index: 1.6
Specification:
Appearance: Colorlesss liquid
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Tasimelteon CAS: 609799-22-6
Contact us for information like 4-ethenyl-2,3-dihydro-1-benzofuran chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzofuran,4-ethenyl-2,3-dihydro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-ethenyl-2,3-dihydro-1-benzofuran Use and application,4-ethenyl-2,3-dihydro-1-benzofuran technical grade,usp/ep/jp grade.
Related News: A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday.Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate manufacturer The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.4-bromoanisole supplier The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.8-fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one vendor The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).
